(19)
(11) EP 1 608 644 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
20.12.2006 Bulletin 2006/51

(45) Mention of the grant of the patent:
02.11.2006 Bulletin 2006/44

(21) Application number: 04721969.6

(22) Date of filing: 19.03.2004
(51) International Patent Classification (IPC): 
C07D 411/04(2006.01)
(86) International application number:
PCT/IB2004/000924
(87) International publication number:
WO 2004/085432 (07.10.2004 Gazette 2004/41)

(54)

PROCESS AND INTERMEDIATES FOR PREPARING EMTRICITABINE

VERFAHREN UND ZWISCHENPRODUKTE FÜR DIE HERSTELLUNG VON EMTRICITABIN

PROCEDE ET INTERMEDIAIRES POUR PREPARER DE L’EMTRICITABINE

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

(30) Priority: 24.03.2003 IT MI20030578

(43) Date of publication of application:
28.12.2005 Bulletin 2005/52

(73) Proprietor: Archimica S.r.l.
20124 Milano (IT)

(72) Inventors:
  • BERTOLINI, Giorgio
    I-20099 Sesto San Giovanni (IT)
  • DELEO, Maurizio
    I-20152 Milano (IT)
  • FRIGERIO, Marco
    I-20147 Milano (IT)
  • LOSA, Massimo
    I-20010 Pogliano Milanese (IT)
  • VELATI, Maurizio
    I-27030 Mezzana Rabattone (IT)

(74) Representative: Pistolesi, Roberto et al
Dragotti & Associati srl Via Turati 32
20121 Milano
20121 Milano (IT)


(56) References cited: : 
EP-A1- 0 515 157
WO-A-92/14743
US-A- 5 696 254
 EP-A1- 0 526 253
WO-A-95/29174
US-B1- 6 329 522
   
  • JEONG, L.S.; ET AL.: J. MED. CHEM., vol. 36, no. 2, 1993, pages 181-195, XP002285252
  • CHU, C.K.; ET AL.: J, MED. CHEM., vol. 43, no. 21, 2000, pages 3906-3912, XP002285253
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).